Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Sah P, Shoukat A, Meyers LA, Galvani AP, Population immunity against COVID-19 in the United States, Annals of Internal Medicine 2021, 174(11):1586-1591.
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer BH, McDonald RH, Fitzpatrick MC, Galvani AP, Optimizing COVID-19 quarantine and testing strategies, Nature Communications 2021, 21: 356.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Wang Z, Röst G, Moghadas SM, Deviation from the recommended schedule: optimal dosing interval for a two-dose vaccination programme, Royal Society Open Science 2024 (in press)
Mehrab Z, Stundal L, Venkatramanan S, Swarup S, Lewis BL, Mortveit HS, Barrett CL, Pandey A, Wells CR, Galvani AP, Singer BH, Moghadas SM, Leblang D, Colwell RR, Marathe MV, A generalizable theory-driven agent-based framework to study conflict-induced forced migration. In Proceedings of the AAAI Conference on Artificial Intelligence 2024, 38: 23027-23033.
Nunes MC, Thommes E, Fröhlich H, Flahault A, Arino J, Baguelin M, Biggerstaff M, Bizel-Bizellot G, Borchering R, Cacciapaglia G, Cauchemez S, Barbier A, Claussen C, Choirat C, Cojocaru M, Commaille-Chapus C, Hon C, Kong J, Lambert N, Lauer KB, Lehr T, Mahe C, Marechal V, Mebarki A, Moghadas SM, Niehus R, Opatowski L, Parino F, Pruvost G, Schuppert A, Thiébaut R, Thomas-Bachli A, Viboud C, Wu J, Crépey P, Coudeville L,Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report, Infectious Disease Modelling 2024, 9: 501-518.
Wells CR, Pandey A, Moghadas SM, Fitzpatrick MC, Singer BH, Galvani AP, Evaluation of strategies for transitioning to annual SARS-CoV-2 vaccination campaigns in the United States, Annals of Internal Medicine 2024 (in press)
Röst G, Wang Z, Moghadas SM, Waiting for the perfect vaccine. BIOMAT Book Series, Springer 2024 (in press)
Shoukat A, Bawden CE, Röst G, LeBlanc JJ, Galvani AP, Langley JM, Moghadas SM, Impact and cost-Effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study, Vaccine 2024, 7: 1768-1776.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP, Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States, Clinical Infectious Diseases 2023, ciad658.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM,Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Xu J, Wang Z, Moghadas SM, Modelling the effect of travel-related policies on disease control in a meta-population structure, Journal of Mathematical Biology 2023, 87: 55.
Pandey A, Fitzpatrick MC, Moghadas SM, Vilches TN, Ko C, Vasan A, Galvani AP, Modelling a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City, The Lancet Regional Health - Americas 2023, 24: 100555.